18th International Conference on Malignancies in HIV/AIDS
October 24 – October 26, 2022
The International Conference on Malignancies in HIV/AIDS is the only forum that is solely focused on presentation of basic, epidemiologic, and clinical aspects of research on malignancies in HIV-infected individuals. Our objective is to enable information exchange between laboratory and clinically based investigators to decrease the interval between basic discovery and clinical application.
This conference will address basic and clinical research on viral oncology, immunology, genetics, epidemiology, pathogenesis, drug discovery, early diagnosis, and clinical investigation in the context of HIV/AIDS. We anticipate an emphasis on human papillomavirus (HPV), Epstein-Barr virus (EBV), and Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) and their related malignancies including lymphomas, ano-genital carcinomas, Kaposi’s sarcoma, and Hodgkin’s disease. Translational objectives such as basic target identification and validation, and preventive or therapeutic interventions are of particular interest. Other topics include interactions between viruses, somatic cell genetic changes, inherited and environmental risk factors, molecular genetics and biomarkers of disease, experimental models, novel clinical and therapeutic observations, epidemiology of etiologic agents or disease and clinical outcomes.
Who should attend the 18th ICMH?
The format will include invited plenaries as well as oral and poster presentations of submitted abstracts. This conference is organized to provide informational and networking resources for all clinical and laboratory investigators; postdocs; students; physicians; health care workers and others involved, interested, or participating in malignancy research in HIV/AIDS and in tumor virology. Participants from resource-limited countries with endemic virus-associated malignancies are encouraged to submit abstracts.